BRINGHEN, Sara

BRINGHEN, Sara  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 61 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials. 2013 Bringhen S;Mateos MV;Zweegman S;Larocca A;Falcone AP;Oriol A;Rossi D;Cavalli M;Wijermans P;Ria R;Offidani M;Lahuerta JJ;Liberati AM;Mina R;Callea V;Schaafsma M;Cerrato C;Marasca R;Franceschini L;Evangelista A;Teruel AI;van der Holt B;Montefusco V;Ciccone G;Boccadoro M;San Miguel J;Sonneveld P;Palumbo A
Approach to the Older Adult With Multiple Myeloma 2019 Mina, Roberto; Bringhen, Sara; Wildes, Tanya M; Zweegman, Sonja; Rosko, Ashley E
Bortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients: update of multicenter, open-label Phase 1/2 study 2017 Grammatico S.; Bringhen S.; Vozella F.; Siniscalchi A.; Boccadoro M.; Petrucci M.T.
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival. 2014 Palumbo A;Bringhen S;Larocca A;Rossi D;Di Raimondo F;Magarotto V;Patriarca F;Levi A;Benevolo G;Vincelli ID;Grasso M;Franceschini L;Gottardi D;Zambello R;Montefusco V;Falcone AP;Omedé P;Marasca R;Morabito F;Mina R;Guglielmelli T;Nozzoli C;Passera R;Gaidano G;Offidani M;Ria R;Petrucci MT;Musto P;Boccadoro M;Cavo M
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA) 2018 Sara Bringhen, Alberto Milan, Claudio Ferri, Ralph Wäsch, Francesca Gay, Alessandra Larocca, Marco Salvini, Evangelos Terpos, Hartmut Goldschmidt, Michele Cavo, Maria Teresa Petrucci, Heinz Ludwig, Holger W. Auner, Jo Caers, Martin Gramatzki, Mario Boccadoro, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies 2021 Mina, Roberto; Bonello, Francesca; Petrucci, Maria Teresa; Liberati, Anna Marina; Conticello, Concetta; Ballanti, Stelvio; Musto, Pellegrino; Olivieri, Attilio; Benevolo, Giulia; Capra, Andrea; Gilestro, Milena; Galieni, Piero; Cavo, Michele; Siniscalchi, Agostina; Palumbo, Antonio; Montefusco, Vittorio; Gaidano, Gianluca; Omedé, Paola; Boccadoro, Mario; Bringhen, Sara
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study. 2014 Bringhen S;Petrucci MT;Larocca A;Conticello C;Rossi D;Magarotto V;Musto P;Boccadifuoco L;Offidani M;Omedé P;Gentilini F;Ciccone G;Benevolo G;Genuardi M;Montefusco V;Oliva S;Caravita T;Tacchetti P;Boccadoro M;Sonneveld P;Palumbo A
Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma 2019 D'Agostino M.; Gazzera G.; Cetani G.; Bringhen S.; Boccadoro M.; Gay F.
Cost efficiency and effectiveness of biosimilar filgrastim in autologous transplant 2022 Giaccone L.; Brunello L.; Londono J.S.; Scaldaferri M.; Cerrano M.; Redoglia V.; Omede P.; Lia G.; Massaia M.; Ferrero D.; Cavallo F.; Bringhen S.; Leone S.; Cattel F.; Francisci T.; Tassi V.; Evangelista A.; Boccadoro M.; Bruno B.
Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma 2014 Bringhen S.; Gay F.; Donato F.; Troia R.; Mina R.; Palumbo A.
Determining treatment intensity in elderly patients with multiple myeloma 2018 Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S.
Does low-molecular-weight heparin influence the antimyeloma effects of thalidomide? A retrospective analysis of data from the GIMEMA, nordic and turkish myeloma study groups 2015 Beksac, Meral; Waage, Anders; Bringhen, Sara; Kristinsson, Sigurdur Y.; Sucak, Gülsan Türköz; Gimsing, Peter; Lupparelli, Giulia; Firatli-Tuʇlular, Tulin; Juliusson, Gunnar; Turesson, Ingemar; Palumbo, Antonio
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma 2021 Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara
Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis 2018 Bringhen, Sara; Offidani, Massimo; Palmieri, Salvatore; Pisani, Francesco; Rizzi, Rita; Spada, Stefano; Evangelista, Andrea; Di Renzo, Nicola; Musto, Pellegrino; Marcatti, Magda; Vallone, Roberto; Storti, Sergio; Bernardini, Annalisa; Centurioni, Riccardo; Aitini, Enrico; Palmas, Angelo; Annibali, Ombretta; Angelucci, Emanuele; Ferrando, Paola; Baraldi, Anna; Rocco, Stefano; Andriani, Alessandro; Siniscalchi, Agostina; De Stefano, Valerio; Meneghini, Vittorio; Palumbo, Antonio; Grammatico, Sara; Boccadoro, Mario; Larocca, Alessandra*
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing 2020 D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca
Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients 2021 Mingrone, Giulia; Astarita, Anna; Airale, Lorenzo; Maffei, Ilaria; Cesareo, Marco; Crea, Teresa; Bruno, Giulia; Leone, Dario; Avenatti, Eleonora; Catarinella, Cinzia; Salvini, Marco; Cetani, Giusy; Gay, Francesca; Bringhen, Sara; Veglio, Franco; Vallelonga, Fabrizio; Milan, Alberto
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients. 2010 Bringhen S;Larocca A;Rossi D;Cavalli M;Genuardi M;Ria R;Gentili S;Patriarca F;Nozzoli C;Levi A;Guglielmelli T;Benevolo G;Callea V;Rizzo V;Cangialosi C;Musto P;De Rosa L;Liberati AM;Grasso M;Falcone AP;Evangelista A;Cavo M;Gaidano G;Boccadoro M;Palumbo A
Emerging drugs and combinations to treat multiple myeloma 2017 Larocca, Alessandra*; Mina, Roberto; Gay, Francesca; Bringhen, Sara; Boccadoro, Mario
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications 2015 Terpos, Evangelos; Kleber, Martina; Engelhardt, Monika; Zweegman, Sonja; Gay, Francesca; Kastritis, Efstathios; van de Donk, Niels W C J; Bruno, Benedetto; Sezer, Orhan; Broijl, Annemiek; Bringhen, Sara; Beksac, Meral; Larocca, Alessandra; Hajek, Roman; Musto, Pellegrino; Johnsen, Hans Erik; Morabito, Fortunato; Ludwig, Heinz; Cavo, Michele; Einsele, Hermann; Sonneveld, Pieter; Dimopoulos, Meletios A; Palumbo, Antonio
Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy 2018 Iannaccone A.; Bruno G.; Ravera A.; Gay F.; Salvini M.; Bringhen S.; Sabia L.; Avenatti E.; Veglio F.; Milan A.